Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

Alison Roos(Mayo Clinic in Arizona), Nhan L. Tran(Mayo Clinic in Arizona)
Oncotarget
January 17, 2017
Cited by 52


Related Papers